8-K: Select Medical Completes Spin-Off of Concentra in $2.3 Billion Distribution

Select Medical Holdings Corporation has finalized the spin-off of Concentra through a special stock distribution to its shareholders, valued at approximately $2.3 billion.

Summary

• Select Medical Holdings Corporation completed the spin-off of Concentra Group Holdings Parent, Inc. on November 25, 2024.
• The spin-off was executed through a special stock distribution of 104,093,503 shares of Concentra common stock.
• Select Medical shareholders received 0.806971 shares of Concentra for each share of Select Medical stock they owned as of November 18, 2024.
• No fractional shares of Concentra were distributed; instead, shareholders will receive cash in lieu of fractional shares.
• Prior to the distribution, Select Medical owned approximately 81.7% of Concentra's outstanding shares.
• Following the distribution, Select Medical no longer owns any shares of Concentra.
• The aggregate market value of the distributed Concentra shares was approximately $2,303.6 million, based on a closing price of $22.13 per share on November 25, 2024.

Sentiment

Score: 7

Explanation: The document reflects a significant corporate restructuring event that was executed as planned. The financial details are complex, but the overall tone is positive, indicating a strategic move to streamline operations. The sentiment is moderately positive due to the completion of the spin-off and the associated financial restructuring.

Positives

• The spin-off allows Select Medical to focus on its core operations.
• Shareholders received a significant distribution of Concentra stock, valued at approximately $2.3 billion.
• The transaction was completed as previously announced.

Negatives

• Select Medical no longer benefits from Concentra's operations and earnings.
• The company incurred a loss on early retirement of debt related to the write-off of unamortized deferred financing fees of $10.9 million for the year ended December 31, 2023.

Risks

• Select Medical's future results may differ from those anticipated due to various market conditions and other factors.
• The company's estimates on a discontinued operations basis could change as the company finalizes discontinued operations accounting to be reported in the 2024 Annual Report on Form 10-K.
• The pro forma financial information is based on current estimates and assumptions and may not reflect actual results.

Future Outlook

Select Medical intends to issue $550 million in senior notes and refinance its existing debt. The company's consolidated financial statements will be updated to reflect Concentra's financial position and results of operations as discontinued operations.

Management Comments

• Select Medical announced that they have completed the distribution of Concentra shares.
• Select Medical stated that the distribution was made to stockholders as of the close of business on the record date, November 18, 2024.

Industry Context

The spin-off of Concentra allows Select Medical to streamline its operations and focus on its core business segments, which include critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. This move is in line with a trend of companies focusing on core competencies and divesting non-core assets.

Comparison to Industry Standards

• The spin-off of Concentra is a significant corporate action, similar to other large healthcare companies that have divested non-core assets to improve focus and shareholder value.
• The financial restructuring, including the issuance of new debt and refinancing of existing debt, is a common practice among companies seeking to optimize their capital structure after a major transaction.
• The pro forma financial statements provide a view of Select Medical's financial position post-spin-off, which is a standard practice for such transactions, allowing investors to assess the impact of the separation.

Stakeholder Impact

• Shareholders of Select Medical received shares of Concentra, impacting their investment portfolio.
• Employees of Select Medical may experience changes due to the restructuring.
• Customers and suppliers of both Select Medical and Concentra will see changes in their respective business relationships.
• Creditors of Select Medical will be impacted by the refinancing of debt.

Next Steps

• Select Medical will issue $550 million in senior notes on or about December 3, 2024.
• The company will amend its existing senior secured credit agreement.
• Select Medical will update its consolidated financial statements to reflect Concentra as discontinued operations.
• The company will finalize discontinued operations accounting to be reported in the 2024 Annual Report on Form 10-K.

Key Dates

Keywords

spin-off, Concentra, Select Medical, stock distribution, healthcare, financial transaction, shareholders, NYSE, SEM, CON